123 related articles for article (PubMed ID: 9871763)
1. High affinity, selective neurokinin 2 and neurokinin 3 receptor antagonists from a common structural template.
Harrison T; Korsgaard MP; Swain CJ; Cascieri MA; Sadowski S; Seabrook GR
Bioorg Med Chem Lett; 1998 Jun; 8(11):1343-8. PubMed ID: 9871763
[TBL] [Abstract][Full Text] [Related]
2. Stepwise modulation of neurokinin-3 and neurokinin-2 receptor affinity and selectivity in quinoline tachykinin receptor antagonists.
Blaney FE; Raveglia LF; Artico M; Cavagnera S; Dartois C; Farina C; Grugni M; Gagliardi S; Luttmann MA; Martinelli M; Nadler GM; Parini C; Petrillo P; Sarau HM; Scheideler MA; Hay DW; Giardina GA
J Med Chem; 2001 May; 44(11):1675-89. PubMed ID: 11356103
[TBL] [Abstract][Full Text] [Related]
3. Mapping the binding pocket of a novel, high-affinity, slow dissociating tachykinin NK3 receptor antagonist: biochemical and electrophysiological characterization.
Malherbe P; Knoflach F; Marcuz A; Bohnert C; Weber M; Knust H; Ratni H; Spooren W; Ballard TM; Bissantz C
Neuropharmacology; 2014 Nov; 86():259-72. PubMed ID: 25107588
[TBL] [Abstract][Full Text] [Related]
4. Characterization of species-related differences in the pharmacology of tachykinin NK receptors 1, 2 and 3.
Leffler A; Ahlstedt I; Engberg S; Svensson A; Billger M; Oberg L; Bjursell MK; Lindström E; von Mentzer B
Biochem Pharmacol; 2009 May; 77(9):1522-30. PubMed ID: 19426690
[TBL] [Abstract][Full Text] [Related]
5. Probing the structure and function of the tachykinin neurokinin-2 receptor through biosynthetic incorporation of fluorescent amino acids at specific sites.
Turcatti G; Nemeth K; Edgerton MD; Meseth U; Talabot F; Peitsch M; Knowles J; Vogel H; Chollet A
J Biol Chem; 1996 Aug; 271(33):19991-8. PubMed ID: 8702716
[TBL] [Abstract][Full Text] [Related]
6. Senktide-induced gerbil foot tapping behaviour is blocked by selective tachykinin NK1 and NK3 receptor antagonists.
Sundqvist M; Kristensson E; Adolfsson R; Leffler A; Ahlstedt I; Engberg S; Drmota T; Sigfridsson K; Jussila R; de Verdier J; Novén A; Johansson A; Påhlman I; von Mentzer B; Lindström E
Eur J Pharmacol; 2007 Dec; 577(1-3):78-86. PubMed ID: 17920583
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and characterization of selective fluorescent ligands for the neurokinin NK2 receptor.
Bradshaw CG; Ceszkowski K; Turcatti G; Beresford IJ; Chollet A
J Med Chem; 1994 Jun; 37(13):1991-5. PubMed ID: 8027981
[TBL] [Abstract][Full Text] [Related]
8. Receptors and antagonists for substance P and related peptides.
Regoli D; Boudon A; Fauchére JL
Pharmacol Rev; 1994 Dec; 46(4):551-99. PubMed ID: 7534932
[No Abstract] [Full Text] [Related]
9. SCH 206272: a potent, orally active tachykinin NK(1), NK(2), and NK(3) receptor antagonist.
Anthes JC; Chapman RW; Richard C; Eckel S; Corboz M; Hey JA; Fernandez X; Greenfeder S; McLeod R; Sehring S; Rizzo C; Crawley Y; Shih NY; Piwinski J; Reichard G; Ting P; Carruthers N; Cuss FM; Billah M; Kreutner W; Egan RW
Eur J Pharmacol; 2002 Aug; 450(2):191-202. PubMed ID: 12206858
[TBL] [Abstract][Full Text] [Related]
10. Discovery of a novel class of selective non-peptide antagonists for the human neurokinin-3 receptor. 2. Identification of (S)-N-(1-phenylpropyl)-3-hydroxy-2-phenylquinoline-4-carboxamide (SB 223412).
Giardina GA; Raveglia LF; Grugni M; Sarau HM; Farina C; Medhurst AD; Graziani D; Schmidt DB; Rigolio R; Luttmann M; Cavagnera S; Foley JJ; Vecchietti V; Hay DW
J Med Chem; 1999 Mar; 42(6):1053-65. PubMed ID: 10090788
[TBL] [Abstract][Full Text] [Related]
11. Biphenyl derivatives as novel dual NK(1)/NK(2)-receptor antagonists.
Mah R; Gerspacher M; von Sprecher A; Stutz S; Tschinke V; Anderson GP; Bertrand C; Subramanian N; Ball HA
Bioorg Med Chem Lett; 2002 Aug; 12(16):2065-8. PubMed ID: 12127505
[TBL] [Abstract][Full Text] [Related]
12. Recent advances in neurokinin receptor antagonists.
Shenvi AB
Curr Top Med Chem; 2003; 3(12):NA. PubMed ID: 12921087
[No Abstract] [Full Text] [Related]
13. Discovery of a novel class of selective non-peptide antagonists for the human neurokinin-3 receptor. 1. Identification of the 4-quinolinecarboxamide framework.
Giardina GA; Sarau HM; Farina C; Medhurst AD; Grugni M; Raveglia LF; Schmidt DB; Rigolio R; Luttmann M; Vecchietti V; Hay DW
J Med Chem; 1997 Jun; 40(12):1794-807. PubMed ID: 9191956
[TBL] [Abstract][Full Text] [Related]
14. Recent advances in neurokinin receptor antagonists.
Gao Z; Peet NP
Curr Med Chem; 1999 May; 6(5):375-88. PubMed ID: 10101218
[TBL] [Abstract][Full Text] [Related]
15. Antagonists at the neurokinin receptors--recent patent literature.
Giardina GA; Gagliardi S; Martinelli M
IDrugs; 2003 Aug; 6(8):758-72. PubMed ID: 12917772
[TBL] [Abstract][Full Text] [Related]
16. Probing the binding domain of the NK2 receptor with fluorescent ligands: evidence that heptapeptide agonists and antagonists bind differently.
Turcatti G; Vogel H; Chollet A
Biochemistry; 1995 Mar; 34(12):3972-80. PubMed ID: 7696262
[TBL] [Abstract][Full Text] [Related]
17. Activity of cyclic pseudopeptide antagonists at peripheral tachykinin receptors.
Patacchini R; Quartara L; Astolfi M; Goso C; Giachetti A; Maggi CA
J Pharmacol Exp Ther; 1995 Mar; 272(3):1082-7. PubMed ID: 7891319
[TBL] [Abstract][Full Text] [Related]
18. Neurokinin receptors in the guinea pig ileum.
Nguyen-Le XK; Nguyen QT; Gobeil F; Jukic D; Chrétien L; Regoli D
Pharmacology; 1996 Jan; 52(1):35-45. PubMed ID: 8966201
[TBL] [Abstract][Full Text] [Related]
19. [Molecular modelling and drug design: neurokinin receptor antagonism].
Boudon A; Jacoby E; Michel A
J Pharm Belg; 1997; 52(2):103. PubMed ID: 9296954
[No Abstract] [Full Text] [Related]
20. Novel potent substance P and neurokinin A receptor antagonists. Conception, synthesis and biological evaluation of indolizine derivatives.
Millet R; Domarkas J; Rigo B; Goossens L; Goossens JF; Houssin R; Hénichart JP
Bioorg Med Chem; 2002 Sep; 10(9):2905-12. PubMed ID: 12110311
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
